Nephros (NEPH) Net Cash Flow Growth (1y) (2011 - 2026)
Nephros (NEPH) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -342.50% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 131.47% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -47.85% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -40.20% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -194.15% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 102.38% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 84.02% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 144.81% |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn | -530.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -530.53% |
| Dec 31, 2025 | -85.88% |
| Sep 30, 2025 | 115.57% |
| Jun 30, 2025 | 297.42% |
| Mar 31, 2025 | 147.63% |
| Dec 31, 2024 | 642.92% |
| Sep 30, 2024 | -210.85% |
| Jun 30, 2024 | -324.55% |
| Mar 31, 2024 | -433.66% |
| Dec 31, 2023 | 21.57% |
| Sep 30, 2023 | 335.15% |
| Jun 30, 2023 | 118.04% |
| Mar 31, 2023 | 113.03% |
| Dec 31, 2022 | 17.74% |
| Sep 30, 2022 | 74.19% |
| Jun 30, 2022 | -1,189.47% |
| Mar 31, 2022 | -1,813.58% |
| Dec 31, 2021 | -112.04% |
| Sep 30, 2021 | 51.13% |
| Jun 30, 2021 | 106.74% |